UM

Browse/Search Results:  1-1 of 1 Help

Selected(0)Clear Items/Page:    Sort:
Risk of antiangiogenic adverse events in metastatic colorectal cancer patients receiving aflibercept in combination with chemotherapy: A meta-analysis Journal article
Ge, Pu, Han, Chunyan, Reyila, Abudurousuli, Liu, Diyue, Hong, Wenying, Liu, Jiaxin, Zhang, Jinzi, Han, Xiao, Li, Xialei, Huang, Mengjie, Fan, Siyuan, Kaierdebieke, Ayidana, Wu, Xiaoyu, Huang, Xiaolu, Guo, Weirui, Liu, Siyu, Bian, Ying. Risk of antiangiogenic adverse events in metastatic colorectal cancer patients receiving aflibercept in combination with chemotherapy: A meta-analysis[J]. Medicine, 2023, 102(35), e34793.
Authors:  Ge, Pu;  Han, Chunyan;  Reyila, Abudurousuli;  Liu, Diyue;  Hong, Wenying; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:1.3/1.6 | Submit date:2023/09/12
Adverse Events  Aflibercept  Antiangiogenesis  Meta-analysis  Metastatic Colorectal Cancer  Safety  Systematic Review